Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study
Marine Drugs · 10.02.2024 · 22 (2) · 83
DOI: 10.3390/md22020083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 10.02.2024. Verfasst von Nan Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Guangdong Medical University, Zhanjiang 524023, China. Hauptthemen laut MEDLINE: Biological Products, Ammonium Compounds. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and technology program of Guangdong Province, The Key Discipline Construction Project of Guangdong Medical University.
Abstract (Originalsprache)
PLK1 is found to be highly expressed in various types of cancers, but the development of inhibitors for it has been slow. Most inhibitors are still in clinical stages, and many lack the necessary selectivity and anti-tumor effects. This study aimed to create new inhibitors for the PLK1-PBD by focusing on the PBD binding domain, which has the potential for greater selectivity. A 3D QSAR model was developed using a dataset of 112 compounds to evaluate 500 molecules. ADMET prediction was then used to select three molecules with strong drug-like characteristics. Scaffold hopping was employed to reconstruct 98 new compounds with improved drug-like properties and increased activity. Molecular docking was used to compare the efficient compound abbapolin, confirming the high-activity status of [(14S)-14-hydroxy-14-(pyridin-2-yl)tetradecyl]ammonium,[(14S)-15-(2-furyl)-14-hydroxypentadecyl]ammonium and [(14S)-14-hydroxy-14-phenyltetradecyl]ammonium. Molecular dynamics simulations and MMPBSA were conducted to evaluate the stability of the compounds in the presence of proteins. An in-depth analysis of [(14S)-15-(2-furyl)-14-hydroxypentadecyl]ammonium and [(14S)-14-hydroxy-14-phenyltetradecyl]ammonium identified them as potential candidates for PLK1 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical College, Guangdong Medical University, Zhanjiang 524023, China.
- The Marine Biomedical Research Institute, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.
- The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.
ORCID-Profile: Lianxiang Luo
Förderung
- The Science and technology program of Guangdong Province
- The Key Discipline Construction Project of Guangdong Medical University
Zitieren
APA
Zhou, N., Zheng, C., Tan, H., & Luo, L. (2024). Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine Drugs, 22(2), 83. https://doi.org/10.3390/md22020083
Vancouver
Zhou N, Zheng C, Tan H, Luo L. Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study. Marine Drugs. 2024;22(2):83. doi:10.3390/md22020083
BibTeX
@article{Zhou2024,
author = {Zhou, Nan and Zheng, Chuangze and Tan, Huiting and Luo, Lianxiang},
title = {Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {2},
pages = {83},
doi = {10.3390/md22020083}
}
EUVIMED